2022 Integrative Dermatology Symposium

FEATURED
SPEAKERS

September 30, 2022 - October 2, 2022

Jason Ezra Hawkes,

MD MS FAAD

Dr. Jason Hawkes is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program’s 2+2 dermatology research track. In addition to being a board-certified dermatologist, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master’s degree in Clinical Investigation from Rockefeller University in NYC.

Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation (NPF) and as a Councilor of the International Psoriasis Council (IPC). He is the recipient of multiple teaching awards and research grants and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 50 peer-reviewed publications and 8 book chapters. Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel, targeted systemic, or biologic therapies.

Jason-Hawkes

IDS 2022 Sessions

If You Don’t Know Jak, You Will Now: Overview and Update in Psoriasis

Day One: Friday, September 30, 2022 | 1:00 PM - 1:30 PM MT:

Provide an overview of the normal function of the JAK-STAT signaling pathway within cells. We will also discuss the research and clinical efforts that led to the development of small molecules that inhibit this intracellular pathway, known as JAK inhibitors, and their potential therapeutic role for chronic inflammatory conditions such as psoriasis and atopic dermatitis. Finally, we will compare and contrast this novel class of medications to current FDA-approved therapies in psoriasis (e.g., efficacy, onset of action, overall safety, and common adverse events).

Speaker

Psoriasis Panel

Day One: Friday, September 30, 2022 | 1:30 PM - 2:30 PM

Psoriasis is a complex disease and management is not a linear process. To understand how different aspects of disease management come together into a harmonious and coherent treatment regimen, an interdisciplinary panel will discuss the various aspects of disease management. Using a case-based discussion, the panel will review the various aspects of treatment.

Speaker